On March 11th, Irina Spacova presented our work on the promising upper respiratory tract isolate Lactobacillus casei AMBR2 at Pharmabiotics 2020 in Paris. Due to our multidisciplinary team, we were able to test a probiotic nasal spray in healthy volunteers.
